Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00083564
Recruitment Status : Terminated (For business reasons)
First Posted : May 28, 2004
Last Update Posted : March 31, 2009
Information provided by:
Poniard Pharmaceuticals